Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on September 1, 2026

12 hours ago

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

12 hours ago

Harrow to Participate in Three Investor Conferences in September 

Indeterminate GlobeNewswire

12 hours ago

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Indeterminate GlobeNewswire

12 hours ago

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Indeterminate GlobeNewswire

12 hours ago

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

Indeterminate GlobeNewswire

12 hours ago

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Indeterminate GlobeNewswire

12 hours ago

HealthTab™ Programme Expands Nationally Across England

Indeterminate GlobeNewswire

14 hours ago

BICEL™ SOFT TIP I/A terralution™. Gentle by Design. Sustainable by Nature*.

Indeterminate GlobeNewswire

15 hours ago

Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis

Indeterminate GlobeNewswire

15 hours ago

ENA Respiratory Awarded Biointelect Venturer Funding to Support New Study in Asthma Patients of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

Indeterminate GlobeNewswire

15 hours ago

Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.

Indeterminate GlobeNewswire

18 hours ago

argenx to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

Indeterminate GlobeNewswire

Sep. 1, 2026

Health-ISAC® Invests in APAC with Key Staff Addition in Australia

Indeterminate GlobeNewswire

Sep. 1, 2026

NexLife Expands Flat-Rate Compounded GLP-1 Program With Microdose and Sublingual Protocols

Indeterminate GlobeNewswire